Premium
Recent trends and future directions in human immunodeficiency virus‐associated cancer
Author(s) -
Shiels Meredith S.,
Goedert James J.,
Engels Eric A.
Publication year - 2010
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.25705
Subject(s) - medicine , multicenter aids cohort study , sarcoma , cancer , human immunodeficiency virus (hiv) , lymphoma , cervical cancer , immunology , immunodeficiency , cohort , virology , sida , viral disease , oncology , pathology , immune system
Malignancies, including the 3 that are part of the definition of the acquired immunodeficiency syndrome (AIDS) (Kaposi sarcoma [KS], non‐Hodgkin lymphoma [NHL], and cervical cancer) as well as certain non‐AIDS–defining cancers, cause significant morbidity and an estimated 33% of the deaths reported among patients infected with the human immunodeficiency virus (HIV). The US Multicenter AIDS Cohort Study (MACS) analysis highlighted several interesting and important trends in AIDS‐defining and non‐AIDS–defining cancers among individuals infected with HIV.